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Abstract
The Cancer Prevention and Control Research Network
is a national network recently established to focus on
developing new interventions and disseminating and
translating proven interventions into practice to reduce
cancer burden and disparities, especially among minority
and medically underserved populations. Jointly funded by
the Centers for Disease Control and Prevention and the
National Cancer Institute, the Cancer Prevention and
Control Research Network consists of sites administered
through Prevention Research Centers funded by the
Centers for Disease Control and Prevention. The five sites
are located in Kentucky, Massachusetts, South Carolina,
Texas, Washington State, and West Virginia. The Cancer
Prevention and Control Research Network’s intervention
areas include primary prevention of cancer through
healthy eating, physical activity, sun avoidance, tobacco
control, and early detection of cancer through screening.
The Cancer Prevention and Control Research Network
uses the methods of community-based participatory
research and seeks to build on the cancer-relevant sys-
tematic reviews of the Guide to Community Preventive
Services. Initial foci for the Cancer Prevention and Control
Research Network’s research work groups include projects
to increase screening for breast, cervical, and colorectal
cancers; to promote informed decision making for prostate
cancer screening; and to validate educational materials
developed for low-literacy populations.
Background
The Cancer Prevention and Control Research Network
(CPCRN) is a federally funded, national network of aca-
demic, public health, and community partnerships that
work together to reduce the burden of cancer, especially
among those disproportionately affected. The CPCRN was
initiated in October 2002, with funding from the Centers
for Disease Control and Prevention (CDC) and the
National Cancer Institute (NCI) as part of their effort to
more effectively translate research into practice. The five
CPCRN sites were selected through a competition among
the CDC-funded Prevention Research Centers (PRCs).
Three sites are operated by individual universities: the
Universities of South Carolina, Texas-Houston, and
Washington. Two sites are operated jointly by pairs of uni-
versities: Boston and Harvard Universities; and the
University of Kentucky and West Virginia University.
This paper introduces the CPCRN; outlines the context for
its creation, along with its goals, structure, and operations;
and summarizes progress to date.
Context
Although the CPCRN sites carry out most of their work
locally, the CPCRN is a national network and was devel-
oped in a national context. The CPCRN is a further step in
efforts by two federal agencies, the CDC and the NCI, to
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translate research into practice with potential for reducing
the cancer burden in the United States, especially among
populations that are disproportionately affected. The con-
text for the CPCRN, discussed in detail below, consists of
four factors. First, the cancer burden in the United States
remains high, and disparities in incidence and mortality
persist. Second, one of the best opportunities to reduce
these disparities is through community-based participato-
ry research. Third, recently published syntheses of
research, such as the CDC’s Guide to Community
Preventive Services (Community Guide) (1), suggest specif-
ic areas where carefully evaluated dissemination research
is needed. Finally, the CDC’s PRC Program (2), with its
focus on community-based participatory research (CBPR)
and translation, provides a unique combination of trained,
experienced investigators and infrastructure to support a
network like the CPCRN.
Cancer burden in the United States
The creation of the CPCRN is, in part, a response to the
growing magnitude of and persistent disparities in cancer
burden. Cancer is the second leading cause of death in the
United States as well as a leading cause of morbidity.
Cancer accounts for one of every four deaths (3), and, in
2004, 563,700 people are expected to die of cancer. In 2004,
1,368,030 new cancer cases are expected to be diagnosed in
the United States (3), not including carcinoma in situ or
basal and squamous cell skin cancers. The top four cancer
sites (with expected numbers of cases) are prostate
(230,110), breast (217,440), lung (173,770), and colorectal
(150,950). In addition, more than 1 million cases of basal
and squamous cell skin cancer are expected to be diag-
nosed in 2004.
Disparities in cancer incidence and mortality persist.
For example, the incidence of cervical cancer is four times
as high among Vietnamese women as it is among other
Asian American and Pacific Islander women (3). Overall,
cancer mortality among African American men is 1.4
times higher than among whites, and cancer mortality
among African American women is 1.2 times higher than
among whites (4). Additional disparities in cancer inci-
dence and mortality rates across major racial and ethnic
groups in the United States are highlighted in recent
reports (3,5) and below in descriptions of the CPCRN sites.
Those disparities are the result of a complex array of eco-
nomic, social, and cultural factors, and these factors are
also reflected in disparities in preventive behaviors. For
example, smoking prevalence is now highest among
American Indian (38.6%) and Alaska Native (27.4%) men
and women (3,5). Screening prevalence for colorectal can-
cer is the lowest among Hispanics and Latinos (3,5). To
optimize the effect of cancer prevention efforts relative to
expenditure, we need to be clear about 1) the efficiency of
intervening on known risk factors early in the natural his-
tory of the carcinogenic process (e.g., reducing use of tobac-
co products, improving access to fresh fruits and vegeta-
bles), 2) the utility of various preventive services (e.g.,
screening), and 3) the willingness of communities to be
engaged in cancer prevention and control.
The importance of community-based participatory
research
The CPCRN embraces the principles of CBPR (6) as core
values. Research and evaluation developed with commu-
nities in a participatory way are more likely to reflect the
needs, interests, and values of the community. Also, after
research funding has ended, the results from such
research and evaluation are more likely to be widely dis-
seminated and the interventions to be sustained (7). The
CPCRN has made a commitment in each of its sites to
implement activities in a manner that is community-based
and participatory to strengthen local resources and to
build the capacity of community organizations to conduct
and translate research. The CPCRN’s commitment to
CBPR is consistent with the strong and growing commit-
ment of funding agencies to support this type of research
partnership (8).
The need for research dissemination and translation
The need for the CPCRN is highlighted by recent reports
of both progress against cancer and remaining challenges
in disseminating and translating knowledge gained from
efficacy and effectiveness research. During the late 1990s,
death rates from the four leading cancers — lung, colorec-
tal, breast, and prostate — declined nationally and in most
states (5). Two important prevention strategies have con-
tributed to this decline but remain underused: 1) primary
prevention by reducing risk behaviors and 2) early detec-
tion by increasing the use of screening services (3).
Both the NCI and the CDC have given high priority to
bridging the dissemination gap. The NCI’s Translating
Research into Improved Outcomes program has identified
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to the adoption of evidence-based cancer control interven-
tion. The program has also identified the need to expand
research/practice partnerships as critical to both the adop-
tion and evaluation of evidence-based interventions in
public health and clinical practice settings (9).
The Community Guide, developed under the aegis of an
independent, nonfederal Task Force on Community
Preventive Services and maintained at the CDC, has pro-
vided a partial summary of the state of the art of commu-
nity-based cancer prevention and control. Based on a sys-
tematic review of the literature, the Community Guide
currently recommends 14 interventions aimed at increas-
ing physical activity, reducing exposure to and use of
tobacco, and reducing exposure to ultraviolet light (Table
1) (10-13). In addition to these recommendations, the Task
Force has recently completed recommendations for
increasing informed decision making regarding cancer
screening (14) and plans to publish its reviews of inter-
ventions to increase cancer screening in 2005.
The CDC has a ready dissemination outlet for proven
intervention strategies through its state-based cancer pre-
vention and control programs: the National Breast and
Cervical Cancer Early Detection Program and the
Comprehensive Cancer Control Program.
The CDC Prevention Research Centers program
The prior investment of the CDC in its PRC program
facilitated the creation of the CPCRN by providing a well-
established administrative home for each of the five sites.
In 1984, Congress created the PRC program at the CDC by
authorizing the funding of academic health centers for
innovative research and demonstration projects to prevent
chronic disease. In 1986, the CDC established three PRCs
for two years. Since then, the funding period has increased
to five years, and the number of centers has grown to 28,
which are located in 25 states.
Three aspects of the PRC program strengthen the
ability of the participating CPCRN sites to design,
implement, and evaluate cancer prevention research
with immediate application to public health practice.
First, the PRC peer-review mechanism involves
researchers experienced with CBPR. The peer review
process provides assurance that applications are scien-
tifically sound and that the research conducted is of
practical use to communities. Second, the program’s
focus on CBPR enhances the likelihood that the PRCs
will evaluate acceptable and sustainable community-
based interventions. Partnerships and collaborations of
PRCs with various entities (e.g., businesses, communi-
ty coalitions, grassroots organizations, private health
care providers, state and local public health agencies,
voluntary health organizations) increase the likelihood
that PRCs will produce evaluations of interventions
that are likely to be translated and sustained. Third,
research conducted among the most disadvantaged and
underserved populations in the nation provides the
PRCs with the opportunity to evaluate the external
validity of interventions among diverse populations,
including the rural poor of Appalachia, African
Americans in South Carolina, public housing residents
in Boston, residents of the U.S.-Mexico border, and log-
gers and pulp-mill workers in Washington State.
Methods
The overall goal for the CPCRN is to conduct communi-
ty-based cancer prevention and control intervention and
dissemination research that extends the knowledge base,
addresses critical gaps, and leads to adoption, replication,
implementation, and dissemination of successful pro-
grams in communities.
The CPCRN addresses gaps and builds on recommenda-
tions in the Community Guide by conducting site-specific
and multisite intervention and dissemination research.
The four specific research areas include 1) research on the
effectiveness of community-based interventions for which
evidence is insufficient to justify a Community Guide rec-
ommendation; 2) research replicating Community Guide-
recommended interventions in populations and settings
where they have not been adequately evaluated; 3)
research on how to disseminate and implement
Community Guide-recommended interventions into com-
munities by public health and community-based organiza-
tions; and 4) evaluation of community programs to deter-
mine their effectiveness.
The initial funding of the CPCRN for a two-year period
supported the development of both local network centers
and the larger national network of the CPCRN sites. At
both levels, expected outcomes are evidence of the net-
works’ existence and viability, including mission and
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vision statements, short- and long-term objectives, and
active working groups. Of special emphasis in the research
arena are efforts to develop strong partnerships with com-
munities bearing the greatest burden from cancer, where
community-based participatory research projects are like-
ly to contribute to the reduction and/or the elimination of
disparities in cancer burden.
Cancer Prevention and Control Research Network struc-
ture and operations
The CPCRN is a national network of five sites, each of
which is a local network of academic, community, and
other organizations with an interest in cancer prevention
and research. The work of the CPCRN is led by a
Coordinating Center that organizes, among other things,
cross-site work groups on research topics of mutual inter-
est to the sites, the CDC, and the NCI. The six sections
that follow describe the work of the Coordinating Center
and of each of the five local sites.
Cancer Prevention and Control Research Network
Coordinating Center
The University of Kentucky and West Virginia
University share the coordinating center role for the
CPCRN. The Coordinating Center guides discussions on
developing research tools for community interventions in
cancer prevention and control, organizes collaborative
activities with CPCRN members and their partners, fos-
ters relationships among CPCRN members and nation-
al/state/local partners to ensure that CPCRN objectives
are being achieved, and provides leadership in developing
and managing the CPCRN operational structure.
Specific activities include 1) developing and implement-
ing a plan and system for effective communication among
CPCRN centers; 2) implementing a collaborative planning
process resulting in a seven-year plan for CPCRN research,
dissemination, and evaluation; 3) implementing processes
and procedures for encouraging PRCs to develop collabora-
tive cancer prevention and control research projects; and 4)
ensuring that external evaluation is conducted and is
focused on the Coordinating Center’s performance.
Alliance for Reducing Cancer, Northwest
The site based at the University of Washington is the
Alliance for Reducing Cancer, Northwest (ARC NW; avail-
able from: URL: http://www.arcnw.org). The mission of the
ARC NW is to increase primary-preventive and early-
detection behaviors to prevent and control cancer in the
Puget Sound region, Washington State, and the Pacific
Northwest. ARC NW is a collaborative effort among the
University of Washington PRC, the American Cancer
Society Great West Division; Fred Hutchinson Cancer
Research Center; Group Health Cooperative of Puget
Sound, a health maintenance organization; Public Health
Seattle and King County, a local health department; the
Puget Sound Neighborhood Health Centers, an organiza-
tion of several community health centers in the region;
Qualis Health, the Medicare quality improvement organi-
zation for Alaska, Idaho, and Washington State; the
Washington State Department of Health; and the
Weyerhaeuser Company, a large timber products company.
Data from the Washington State Behavioral Risk Factor
Surveillance System reveal underuse of primary-preven-
tive and early-detection behaviors. In 2002, 21% of
Washingtonians aged 18 or older smoked, 15% were phys-
ically inactive during leisure time, 76% ate inadequate
quantities of fruits and vegetables, and 60% were over-
weight or obese. Also in 2002, among appropriate age
groups, 45% had never received a flexible sigmoidoscopy or
colonoscopy, 40% had never received a fecal occult blood
test, 26% had not received a mammogram within two
years, and 13% had not received a Papanicolaou (Pap) test
within three years (15).
One important factor in the underuse of these behaviors
is the lack of support for prevention at the worksite and in
employer-based health insurance. At the worksite,
employers of all sizes reported in a 2001 national survey
the following offerings: 11% offered fitness services and 5%
offered tobacco-cessation services (personal communica-
tion, Maris Bondi, Partnership for Prevention, November
2003). Employers of all sizes nationwide reported in the
same survey the following health insurance offerings: 80%
covered mammograms, 79% covered Pap smears, 68% cov-
ered colorectal cancer screening, and 10% covered smoking
cessation treatment that included both prescription med-
ications and counseling.
The ARC NW focuses on employed populations and on
underserved communities. Five current activities include
1) a pilot test, involving the Weyerhaeuser Company, of a
policy intervention to promote primary prevention and
early detection via the worksite and employment-based
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team-oriented intervention to promote primary prevention
and early detection of cancer; 3) a pilot test of a tool to
increase informed decision making regarding prostate can-
cer screening; 4) assistance to the Washington State
Department of Health in designing and evaluating its col-
orectal and prostate cancer screening programs; and 5) a
review of the literature regarding the quality of life after
treatment of prostate cancer.
Appalachian Cancer Research Consortium
The site based at the University of Kentucky and West
Virginia University is the Appalachian Cancer Research
Consortium (ACRC). The target population of the ACRC
includes the poor, medically underserved, and primarily
rural residents of West Virginia and the 51 counties in
Appalachian Kentucky. The two universities have a long
history of collaboration, with extensive experience in work-
ing with communities throughout Appalachia on critical
health issues.
The U.S. Department of Health and Human Services
considers the rural residents of Appalachia a “special pop-
ulation” (16). These residents tend to be older, poorer, less
educated, and more likely to be uninsured than urban
Americans. Rural communities have higher rates of chron-
ic illness and disability and report poorer overall health
status than urban communities (16). Residents of rural
areas generally have fewer visits with physicians and
lower levels of preventive care. In addition to factors relat-
ed to rural health status and practices, there are systemic
factors related to rural life that may contribute to less than
optimal preventive care (17). These factors include lack of
public transportation, lack of health care providers, and
lower levels of community services.
As a result, West Virginia and the Appalachian regions
of Kentucky have higher total cancer mortality rates than
the national average (18,19). Both states rank among the
top 10 U.S. states for total, male, and female cancer mor-
tality. Lung cancer is a significant problem for residents,
accounting for approximately 30% of all cancer deaths in
West Virginia and Kentucky and resulting in a higher
lung cancer mortality rate than the U.S. rate. Kentucky
and West Virginia have invasive cervical cancer incidence
and mortality rates that are significantly higher than the
U.S. rates. West Virginia and Appalachian Kentucky also-
have higher colorectal cancer mortality rates than the
United States and Appalachia as a whole. Breast cancer
mortality rates are similar to national rates, but breast
cancer mortality in several rural counties exceeds the
national rate by more than 50%.
The ACRC focuses its efforts primarily on four cancer
sites — lung, cervix, colorectal, and breast — with high
disease burden, high behavioral risks, and high impor-
tance to community members in the region. Current activ-
ities of the ACRC include 1) developing a standardized
assessment tool to evaluate readability, format, illustra-
tions, and content of cancer prevention and control mate-
rials; 2) developing a protocol for colorectal cancer inter-
vention for men and women aged 50 and older; and 3) con-
ducting work site focus groups to identify barriers to col-
orectal screening for public employees aged 50 and older.
Latinos in a Network for Cancer Control
The site based at the University of Texas (UT) is Latinos
in a Network for Cancer Control (LINCC; available from:
URL: http://www.sph.uth.tmc.edu/research/lincc). The
mission of the LINCC is to reduce cancer-related health
disparities among Hispanics/Latinos through community-
based intervention, replication, and dissemination
research. LINCC is a collaboration among 1) academic
researchers at the UT School of Public Health, the UT
M.D. Anderson Cancer Center, and the Baylor College
ofMedicine; 2) cancer control organizations, including the
American Cancer Society, Cancer Information Service,
Sanchez Cancer Center, Texas Cancer Council, Texas
Comprehensive Cancer Coalition, and the Texas
Department of Health; and 3) community-based organiza-
tions, including the Center for Border Health Research,
Hispanic Health Coalition, Migrant Health Promotion, the
National Center for Farmworker Health, and the Racial
and Ethnic Approaches to Community Health coalition.
Hispanics/Latinos in Texas account for approximately
25% of the total U.S. Hispanic population and 32% of the
total Texas population (20). Along the U.S.-Mexico border
where LINCC has focused its initial research efforts,
Hispanics comprise roughly 80% of the population (21).
Many border residents experience high rates of poverty
and live in colonias, unincorporated areas where environ-
mental pollution, inadequate wastewater systems, and
inadequate access to public drinking water compound
socioeconomic influences on health behavior.
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Hispanics in the United States experience higher inci-
dence rates of cervical cancer per 100,000 (16.3) compared
with non-Hispanics (7.8) and higher rates of mortality per
100,000 (3.7 compared with 2.6) (22). Along the U.S.-
Mexico border, the disparity is even greater: the incidence
rate of cervical cancer per 100,000 among Hispanics (18.7)
is higher than the rate among non-Hispanics (8.2), and the
mortality rate among Hispanics (6.2) is higher than the
rate among non-Hispanics (3.4) (23). In addition,
Hispanics have lower rates of cancer screening. Only 27%
of the older Hispanic adults in Texas reported having a
recent fecal occult blood test for colorectal cancer (com-
pared with 34% among non-Hispanic whites), and only
50% reported regular mammography use (compared with
60% for non-Hispanic whites) (24). Use of Pap tests for cer-
vical cancer screening among Hispanics (83%) was also
lower compared with non-Hispanic whites (87%) (22).
Current LINCC activities include 1) new research on
factors influencing colorectal cancer screening among
Hispanics and the development of a community-based
intervention to increase this screening; 2) research on
informed decision making for prostate and colorectal can-
cer screening; 3) an evidence review and new research on
lay health-worker- (promotora-) based interventions for
increasing cancer screening; and 4) research on the effec-
tiveness of small media interventions to increase cancer
screening. Another major focus of LINNC is to identify
important factors and effective strategies for replicating
and disseminating effective cancer control interventions in
Hispanic communities. To this end, LINCC is conducting
research on the replication and dissemination of an evi-
dence-based, effective breast and cervical cancer screening
intervention for Hispanic women: Cultivando la Salud
(Cultivating Health) (25).
Massachusetts Cancer Prevention Community Research
Network
The site based at Boston and Harvard Universities is the
Massachusetts Cancer Prevention Community Research
Network (MCPCRN). The MCPCRN’s mission is to foster
a network of partnerships among cancer prevention
researchers and community collaborators to support
CBPR and to reduce social disparities in cancer risk. The
MCPCRN is a collaboration of the Dana-Farber/Harvard
Cancer Center Risk Reduction Program, the Harvard
Prevention Research Center (HPRC), and the Boston
University Prevention Research Center, with participa-
tion from the American Cancer Society’s New England
Division and the Massachusetts Cancer Control Coalition.
Massachusetts has 6.5 million residents, 82% of whom
are non-Hispanic white (26). In Boston, however, because
of recent immigration, non-Hispanic whites are no longer
in the majority (27). The total cancer incidence rate per
100,000 in Massachusetts (501.2) is higher than the nation-
al rate (468.9) in the Surveillance, Epidemiology, and End
Results Program, and so are the incidence rates for
prostate, breast, lung, and colorectal cancers (4,28). The
total cancer mortality rate per 100,000 in Massachusetts
(211.3) is just slightly higher than the U.S. rate (206.0)
(4,28); and colorectal and breast cancers are the major con-
tributors with higher mortality rates. Smoking rates have
fallen to less than 19%, but 20.8% of the population is
sedentary, and 54.4% is overweight or obese (15).
To reduce these risks, the MCPCRN is approaching four
priority community sectors: 1) schools and youth, 2) work
sites and labor unions, 3) health care providers, 4) and low-
income housing. Among schools and youth, the HPRC fac-
ulty direct a range of school and community-based
research to improve youth nutrition and physical activity.
Work sites and union partners include the Massachusetts
AFL-CIO (American Federation of Labor-Congress of
Industrial Organizations), the Massachusetts Coalition on
Occupational Safety and Health, and individual local
unions. Approximately 50 community health centers,
many with strong ties to MCPCRN partners, facilitate
access to health care providers in Massachusetts. The cost
of housing in Massachusetts ranks third nationally;
MCPCRN collaborators have identified more than 100
housing developments in Boston, Cambridge, and
Somerville as potential partners.
The MCPCRN’s current objectives are to strengthen ties
with communities and to conduct pilot and developmental
studies as a foundation for future research. An upcoming
conference on CBPR will emphasize engaging community
organizations in cancer prevention research opportunities.
Collaborative community efforts support Health
Ambassadors for African American and African immi-
grant women in Boston and train tobacco advocates in
housing developments. Developmental research includes a
work site protocol to increase informed decision making for
prostate cancer screening; materials to promote timely fol-
low-up for abnormal mammograms among low-income,
ethnic minority women; and methods to improve decision
6 Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2005/jan/04_0059.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.making on colorectal cancer screening. Pilot studies
include an intervention aimed at weight reduction and
increased physical activity through the Young Men’s
Christian Association and data collection in low-income
housing developments.
South Carolina Cancer Prevention and Control Research
Network
The site based at the University of South Carolina is the
South Carolina Cancer Prevention and Control Research
Network (SCCRN). The SCCRN was created to address
the large and growing cancer burden among African
Americans living in South Carolina. Its aim is to serve the
entire state, with a population of just more than 4 million
people, comprising an area of 31,000 square miles, and
ranging from a long, broad coastal plain to the Piedmont
region of southern Appalachia. The SCCRN builds on a
strong network of existing programs that have coalesced
recently in the South Carolina Cancer Alliance (SCCA),
which consists of more than 750 institutional and individ-
ual members. The constituent bodies of the SCCA include
the South Carolina Department of Health and
Environmental Control and numerous grassroots organi-
zations in addition to all academic, clinical care, and non-
governmental organizations with cancer-related missions.
South Carolina is a relatively rural state, with very high
(>40%) African American representation in rural areas. It
is also a poor state, where the average personal income is
about 81% of the national average (29). Cancer rates of
African Americans, who represent 31% of South Carolina’s
total population, diverge from the U.S. average, in many
instances markedly (4,30). For example, prostate cancer
incidence among African American men in South Carolina
is more than 70% higher than in white men, whereas the
difference is 55% nationally (30). Nearly all cancers have
higher mortality in South Carolina than in the United
States as a whole (4). Illustrative of the pattern of
increased mortality, breast cancer incidence in South
Carolinian African American women is 18% lower than
the incidence in white women (as opposed to being 15%
lower nationally), but mortality is 47% higher (vs the
national differential of 32%) (4,30).
Research at the SCCRN focuses on investigating ways
to implement programs that complement existing cancer
prevention and control infrastructure and through which
we can anticipate risk reduction based on changes in indi-
vidual and organizational behavior. The SCCRN focuses
on breast, cervix, colorectal, oropharyngeal, prostate, and
thoracic cancers. Ongoing projects include 1) investiga-
tion of small media approaches to increase breast and cer-
vical cancer screening in low-income, rural women at
highest risk of aggressive forms of these cancers, 2)
research on informed decision making for prostate cancer
screening and treatment, and 3) identification of geo-
graphical determinants of prostate cancer. Formative
work includes 1) exploration of a community-based,
statewide program of research in oral cancer precancer-
ous lesions, 2) development of a mammography registry to
understand patterns of use in low-income, predominantly
African American populations, and 3) a church-based par-
ticipatory intervention of lay health advocate-delivered
cancer education and referral.
Consequences
In its first year of operation, the CPCRN has focused on
a strategic planning process. From the beginning, commu-
nity partners from each of the five sites have played strong
and active roles in these processes. The strategic planning
process produced vision and mission statements; a set of
operating structures, principles, and plans; and four
research work groups (see below).
Vision statement
Communities and researchers working together to
reduce the burden of cancer, especially among those dis-
proportionately affected.
Mission statement
The mission of the CPCRN is to conduct cancer preven-
tion and control research that extends the knowledge base,
addresses critical gaps, and leads to adoption, replication,
implementation, diffusion, and evaluation of successful
programs in communities.
Operating structure, principles, and plans
The CPCRN has developed a governing structure with a
steering committee, guiding principles, and a seven-year
strategic plan. Further information on each of these docu-
ments is available from: URL: http://ukprc.uky.edu/
CPCRN/home.htm.
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Research work groups
The strategic planning process also suggested the devel-
opment of work groups to initiate and carry out CPCRN
research. The CPCRN currently has work groups focusing
on 1) screening for breast and cervical cancers; 2) screen-
ing for colorectal cancer; 3) informed decision making and
quality-of-life issues for prostate cancer screening and
treatment; and 4) validating low-literacy educational and
media materials. The work groups involve cross-site col-
laboration among scientists from the network centers and
have established research goals (Table 2).
Interpretation
The CPCRN represents a new and innovative
approach for addressing the challenge of identifying
effective interventions and promoting dissemination
and adoption of these interventions into communities.
The CPCRN sites are geographically distributed
across the nation, enhancing opportunities to develop
community partnerships and to conduct community-
based assessments, evaluation, and research with pop-
ulations that represent nearly all types of medically
underserved racial and ethnic groups in the continen-
tal United States. A strong commitment to CBPR
increases the likelihood that CPCRN research will
benefit the underserved communities in greatest need.
The CPCRN also provides an opportunity for the sites
to collaborate in addressing research gaps, including
dissemination research and research translation, and
to build on recommendations provided in the
Community Guide. Finally, the location of the CPCRN
within the CDC’s PRC program enables its research
findings to be easily translated, both nationally and
locally, through long-existing partnerships with other
prevention organizations.
Fostering the optimal results from the CPCRN will
require that its members maintain a delicate balance
between coordinated, centralized efforts and retaining
and enhancing the critical, locally responsive nature of
its individual members. Within the tension between cen-
tralization and decentralization lies the exciting oppor-
tunity to create new strategies for successfully reducing
the burden of cancer, especially among those dispropor-
tionately affected.
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Tables
Table 1. Cancer Prevention Interventions Recommended by the Guide to Community Preventive Services (10-12)
Reducing Tobacco Use and Exposure
Increasing Physical Activity  to Environmental Smoke   Reducing Exposure to Ultraviolet Light 
Behavioral and social approaches
• Individually adapted programs 
• School-based physical education 
• Group programs that foster social sup-
port 
Environmental and policy approaches
• Enhanced access to facilities, with infor-
mational outreach 
• Stair-use reminders 
• Informational approaches
Community-wide campaigns 
• Stair-use reminders 
Increasing cessation
• Increasing the price of tobacco products 
• Mass media campaigns 
• Provider reminders 
• Reducing treatment out-of-pocket costs 
• Telephone quit lines 
Reducing exposure to environmental 
tobacco smoke
• Smoking bans and restrictions 
Reducing initiation
• Increasing the price of tobacco products 
• Mass media campaigns 
Setting-specific approaches
• Primary schools: education and policies 
• Recreation/tourism: education and poli-
cies 
Table 2. The Cancer Prevention and Control Research Network (CPCRN) Research Work Groups and Their Goalsa
Work Group Research Goals 
Colorectal cancer
Breast and cervical cancers
• Develop a protocol for a community-based intervention trial to increase colorectal cancer
screening and promote informed decision making for colorectal cancer screening among
Hispanics.
• Develop a protocol for implementing an intervention to increase colorectal cancer screening
among men and women aged 50 and older.
• Design a small-media community-intervention trial to increase the use and awareness of the
CDC’s National Breast and Cervical Cancer Early Detection Program among program-eligible
African American women.
• Replicate small-media interventions to increase breast and cervical cancer screening among
Hispanics (both farm-working and non-farm-working populations) living in the Texas-Mexico bor-
der area.
(Continued on next page)Table 2. (continued) The Cancer Prevention and Control Research Network (CPCRN) Research Work Groups and Their Goalsa
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Work Group Research Goals 
Prostate cancer
Low-literacy materials validation
• Develop and pretest a work site intervention protocol to increase informed decision making for
prostate cancer screening among men aged 50 and older.
• Develop an interactive and innovative decision-making tool to promote informed decision mak-
ing for prostate cancer screening among men aged 40 to 70.
• Conduct and write a review of available literature regarding the effect of treatment on health-
related quality of life among prostate cancer survivors, with an emphasis on African American
men.
• Identify a care provider network that serves African American men and supports informed and
shared decision making for prostate cancer screening; assess the network’s acceptance and
perception of the usefulness and relevance of NCI materials for informed decision making, and
field test these materials with African American men.
• Provide CPCRN sites and others with an extensive collection of tested materials for individuals
who are among several minority and ethnic populations and have limited reading skills, and
develop tools the CPCRN sites can use to validate materials.
• Conduct a review of existing materials that address the need for timely follow-up of mammo-
graphic abnormalities among low-income ethnic minority women and, where needed, adapt
materials to better meet the needs of these women.
aCDC indicates the Centers for Disease Control and Prevention; NCI indicates National Cancer Institute.